Extracellular matrix is a source of mitogenically active platelet-derived growth factor.
Platelet-derived growth factor (PDGF) is a chemotactic and mitogenic agent for fibroblasts and smooth muscle cells and plays a key role in the development of atherosclerotic lesions. PDGF is produced by a number of normal and transformed cell types and occurs as homo- or heterodimers of A and B polypeptide chains. Using Chinese hamster ovary (CHO) cells transfected with various forms of PDGF, we have previously shown that PDGF A(s) (short splice version) is secreted, PDGF A(l) (long splice version) predominantly extracellular matrix-associated, and PDGF B divided between medium, cells, and matrix. In the present study we have demonstrated the mitogenic activity of matrix-localized PDGF in artificial and more physiologically relevant models by culturing Balb/c-3T3 cells (3T3), human foreskin fibroblasts (HFF), and rabbit aortic smooth muscle cells (SMC) on extracellular matrix (ECM) laid down by PDGF-expressing CHO cells and human umbilical vein endothelial cells (HUVEC). These cells responded to the local growth stimulus of PDGF-containing CHO ECM and HUVEC ECM. We showed that 3T3 cells required proteolytic activity to utilize matrix-localized PDGF, as aprotinin and epsilon-ACA inhibited growth and 3T3 cells were shown to possess plasminogen activator activity. HFF and SMC did not appear to require proteolytic activity (including metalloproteinase and serine protease activity) as a prerequisite for mitogenesis but were able to access immobilized PDGF by contact with the matrix. An understanding of the mechanisms whereby the utilization of stored PDGF is controlled in situations of excessive cellular proliferation will aid in the development of therapy for these conditions.
Field
S L
SL
Centre for Thrombosis and Vascular Research, School of Pathology, Prince of Wales Hospital, University of New South Wales, Sydney, Australia.
Khachigian
L M
LM
Sleigh
M J
MJ
Yang
G
G
Vandermark
S E
SE
Hogg
P J
PJ
Chesterman
C N
CN
D016475:3T3 Cells; D000818:Animals; D000906:Antibodies / Q000276:immunology; D015153:Blotting, Western; D016466:CHO Cells; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D006224:Cricetinae; D004730:Endothelium, Vascular; D005109:Extracellular Matrix / Q000378:metabolism*; D005341:Fibrinolysin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006801:Humans; D051379:Mice; D008934:Mitogens / Q000494:pharmacology*; D009154:Mutation; D010960:Plasminogen Activators / Q000378:metabolism; D010982:Platelet-Derived Growth Factor / Q000276:immunology / Q000378:metabolism* / Q000494:pharmacology; D011817:Rabbits; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology; D014162:Transfection
D000906:Antibodies; D008934:Mitogens; D010982:Platelet-Derived Growth Factor; D015842:Serine Proteinase Inhibitors; D010960:Plasminogen Activators; D005341:Fibrinolysin